Peritoneal exudate cells (PEC) from C3H/He mice given bakers' yeast mannans, WNM and WAM025, showed marked cytolytic activity against MM46 tumor cells in vitro. Because the cytotoxicity of the PEC was strongly inhibited by actinomycin D, it was assumed that the cytolytic factor was a proteinous material(s). Of the macrophages and polymorphonuclear leucocytes (PMN ) separated from the PEC, only the former cells were found to display cytolytic activity. Quinacrine, a phospholipase A2, inhibitor, and sodium azide, a myeloperoxidase inhibitor, did not reduce the cytotoxicity of macrophages from mice treated with acidic mannan (WAM025). In contrast, diisopropylfluorophosphate, a serine protease inhibitor, inhibited the cytolysis of the MM46 target cells by WAM025-treated macrophages. Chymostatin, a chymotrypsin inhibitor, and elastatinal, an elastase inhibitor, also inhibited the cytolytic effect. It is therefore concluded that serine proteases secreted into the medium from the macrophages activated by mannans participated in the cytolytic destruction of neoplasmic cells. Macrophage activation for nonspecific tumoricidal activity against target tumor cells can be induced by various immunopotentiators. In. our previous reports, it was found that mannan of bakers' yeast was able to enhance the immunological response of mice to transplanted tumor cells and to lethal infection with pathogenic microbes.1-4) In order to identify the competent cells in acidic mannan (WAM025)-treated peritoneal exudate cells (PEC), we carried out an in vitro cytolysis assay by macrophages and polymorphonuclear leucocytes (PMN) separated from the PEC by the Percoll gradient centrifugation technique.5) The results indicated that WAM025-treated macrophages were able to display a marked cytolytic effect, while PMN from the same source did not show the effect. Because the chemical entity involved in the cytolysis of tumor cells by WAM025-treated macrophages remained to be identified, we attempted to characterize the cytolytic factor elicited in mouse macrophages by the administration of the yeast mannans.
Macrophage activation for nonspecific tumoricidal activity against target tumor cells can be induced by various immunopotentiators. In. our previous reports, it was found that mannan of bakers' yeast was able to enhance the immunological response of mice to transplanted tumor cells and to lethal infection with pathogenic microbes. [1] [2] [3] [4] In order to identify the competent cells in acidic mannan (WAM025)-treated peritoneal exudate cells (PEC), we carried out an in vitro cytolysis assay by macrophages and polymorphonuclear leucocytes (PMN) separated from the PEC by the Percoll gradient centrifugation technique.5) The results indicated that WAM025-treated macrophages were able to display a marked cytolytic effect, while PMN from the same source did not show the effect. Because the chemical entity involved in the cytolysis of tumor cells by WAM025-treated macrophages remained to be identified, we attempted to characterize the cytolytic factor elicited in mouse macrophages by the administration of the yeast mannans.
The relevancy of serine protease release to tumoricidal activity of macrophages has been reported in mice treated with BCG6,7) and Nocardia rubra cell-wall skeleton.8) However, the real cytolytic factors of antitumor polysaccharide-treated macrophages have not been elucidated to date, although many reports have been published on identifying various lytic factors produced by cytolytically activated macrophages such as oxygen intermediates,9,10) lysosomal enzymes,11,12) proteases,6,7) complement component C3,13) tumor necrotic factor,14) prostaglandins, 15) and myeloperoxidase.16) Therefore, the present study was designed to investigate the possible role of serine proteases in the cytolysis of target tumor cells by antitumor mannan-induced macrophages. Inhibitors Actinomycin D, quinacrine and sodium azide were purchased from Nakarai Chemicals, Ltd, Kyoto. DFP was purchased from Sigma Chemical Co., St. Louis, Mo., U.S.A. The inhibitor solutions were prepared by dissolving the chemicals in RPMI 1640 medium daily. Chymostatin and elastatinal were obtained from the Protein Research Foundation, Minoh, Osaka; stock solutions (10 mg/ml) in dimethyl sulfoxide, were prepared.
Results and Discussion
The cytolytic activities of PEC obtained from WNM-and WAM025-treated mice were assayed against MM46 tumor cells, in the presence or absence of actinomycin D. Table I shows that the PEC from mice treated with either mannan displayed a marked cytolytic effect. It has been reported by Ito et al.8) reported that enzymatically active membrane-bound serine proteases were essential for human PMN and macrophages to initiate and maintain O-2 production in response to stimuli. Our previous paper5) and the present data showed that superoxide release from the PMN was clearly, higher than that from the macrophages, but the PMN did not show any tumoricidal activity. Thus, it is suggested that serine protease-producing activity of macrophages is not always related to the active oxygen releasing activity of the same cells.
